NCT05842408View on ClinicalTrials.gov

Clinical Trial of DA-5212 in Patients with Functional Dyspepsia

PHASE3CompletedINTERVENTIONAL
Enrollment

384

Participants

Timeline

Start Date

June 6, 2023

Primary Completion Date

September 4, 2024

Study Completion Date

September 4, 2024

Conditions
Functional Dyspepsia
Interventions
DRUG

DA-5212

Test drug: DA-5212

DRUG

DA-5212-R

Control drug: DA-5212-R

Trial Locations (1)

54538

Wonkwang University Hospital, Iksan

All Listed Sponsors
lead

Dong-A ST Co., Ltd.

INDUSTRY

NCT05842408 - Clinical Trial of DA-5212 in Patients with Functional Dyspepsia | Biotech Hunter | Biotech Hunter